Case Study: Protocol NI-MC304
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
Study Objectives and Results
Objectives
- Global Enrollment Goal: 80 Participants
- QCR Enrollment Goal: 10 Participants
- Enrollment Window: 5 Months
- Target Population: Ages 6 months and older
- Disease Characteristics: Minimum of 3 and a maximum of 70 MC lesions at baseline
Quality Clinical Research achieved its enrollment goal 3 months before the enrollment window closed. Given this success, QCR was authorized to enroll beyond its initial target. This study had competitive enrollment and QCR outpaced average site enrollment. QCR’s contribution underscored its ability to exceed ambitious enrollment goals, reflecting its operational excellence.
Our site enrolled over 25% of the global enrollment goal for this study.
Result 01
21 Patients Enrolled
Result 02
26.25% of Trial Population
Result 03
Outpaced Average Site Enrollment
